Document:

Exhibit 10.2

 

COMPANY SUPPORT AGREEMENT

 

This COMPANY SUPPORT AGREEMENT (this “Agreement”)
is entered into as of June 29, 2021, by and among FS Development Corp. II, a Delaware corporation (“Parent”), and the
persons set forth on Schedule I attached hereto (each, a “Stockholder” and collectively, the “Stockholders”).
Each of Parent and each Stockholder are sometimes referred to herein individually as a “Party” and collectively as
the “Parties”. Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in
the Merger Agreement (as defined below).

 

RECITALS

 

WHEREAS, concurrently
herewith, Parent, Orchard Merger Sub, Inc., a Delaware corporation (“Merger Sub”), Shareholder Representative Services
LLC, a Colorado limited liability company as the Stockholders’ Representative, and Pardes Biosciences, Inc., a Delaware corporation
(the “Company”), are entering into that certain Agreement and Plan of Merger (as amended, supplemented or otherwise
modified from time to time in accordance with its terms, the “Merger Agreement”) pursuant to which, among other things,
Merger Sub will merge with and into the Company, with the Company as the surviving company in the merger and, after giving effect to such
merger, becoming a wholly-owned Subsidiary of PubCo, and each share of Company Capital Stock (including the Subject Company Shares (as
defined below)) will be converted, either directly or indirectly, into the right to receive PubCo Common Shares, in each case, on the
terms and subject to the conditions set forth in the Merger Agreement;

 

WHEREAS, each Stockholder
is the record and beneficial owner of the number and type of Company Securities set forth on Schedule I hereto (together with any
other Company Securities or other equity interests (including anything convertible into such equity interests) of the Company of which
each Stockholder acquires record or beneficial ownership after the date hereof, collectively, the “Subject Company Shares”);

 

WHEREAS, in consideration
for the benefits to be received by each Stockholder under the terms of the Merger Agreement and as a material inducement to Parent and
the other Parent Parties agreeing to enter into and consummate the transactions contemplated by the Merger Agreement, each Stockholder
agrees to enter into this Agreement and to be bound by the agreements, covenants and obligations contained in this Agreement; and

 

WHEREAS, the Parties
acknowledge and agree that Parent and the other Parent Parties would not have entered into and agreed to consummate the transactions contemplated
by the Merger Agreement without each Stockholder entering into this Agreement and agreeing to be bound by the agreements, covenants and
obligations contained in this Agreement.

 

     

     

    

 

NOW, THEREFORE, in
consideration of the premises and the mutual promises set forth herein and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the Parties, each intending to be legally bound, hereby agree as follows:

 

AGREEMENT

 

1. 
Company Stockholder Consent and Related Matters. 

 

(a) 
(1) As promptly as reasonably practicable (and in any event within five (5) Business Days) following the S-4 Effective Date, each
Stockholder shall duly execute and deliver to the Company and Parent the Company Stockholder Written Consent under which it shall irrevocably
and unconditionally consent to the matters, actions and proposals contemplated by Section 7.1(a) (Company Stockholder Approval) of the
Merger Agreement. Without limiting the generality of the first sentence of this Section 1(a), prior to the Closing, each Stockholder
shall vote (or cause to be voted) the Subject Company Shares against, and shall withhold consent with respect to, any Alternative Transaction.
(2) In addition to the foregoing, each Stockholder hereby unconditionally and irrevocably agrees that, at any meeting of the holders of
Company Capital Stock (or any adjournment or postponement thereof), such Stockholder shall, if a meeting is held, appear at the meeting,
in person or by proxy, or otherwise cause its Subject Company Shares to be counted as present thereat for purposes of establishing a quorum,
and such Stockholder shall vote or provide consent (or cause to be voted or consented), in person or by proxy, all of its Subject Company
Shares:

 

(i) to
approve and adopt the Merger Agreement and the Transactions, including the Merger and the Company Preferred Stock Conversion;

 

(ii) 
in any other circumstances upon which a consent or other approval is required under the organizational
documents of the Company or otherwise sought with respect to the Merger Agreement or the Transactions, to vote, consent or approve (or
cause to be voted, consented or approved) all of such Stockholder’s Subject Company Shares held at such time in favor thereof;

 

(iii) against any Alternative Transaction, or any other merger agreement, merger, consolidation, combination,
sale of substantial assets, reorganization, recapitalization, dissolution, liquidation or winding up of or by the Company (other than
the Merger Agreement and the Transactions); and

 

(iv) against any proposal, action or agreement that would (A) impede, frustrate, prevent or nullify any
provision of this Agreement or the Merger Agreement or otherwise impede, frustrate, prevent or nullify the Merger or any of the Transactions,
(B) result in a breach in any respect of any covenant, representation, warranty or any other obligation or agreement of the Company under
the Merger Agreement or any Additional Agreement to which the Company is a party or (C) result in any of the conditions set forth in Article
IX of the Merger Agreement not being fulfilled.

 

(b) Without limiting any other rights or remedies of Parent, each Stockholder hereby irrevocably appoints Parent or any individual
designated by Parent as the Stockholder’s agent, attorney-in-fact and proxy (with full power of substitution and resubstituting),
for and in the name, place and stead of the Stockholder, to attend on behalf of the Stockholder any meeting of the holders of Company
Capital Stock with respect to the matters described in Section 1(a), to include the Subject Company Shares in any computation for
purposes of establishing a quorum at any such meeting of the holders of Company Capital Stock, to vote (or cause to be voted) the Subject
Company Shares or consent (or withhold consent) with respect to any of the matters described in Section 1(a) in connection with
any meeting of the holders of Company Capital Stock or any action by written consent by the holders of Company Capital Stock (including
the Company Stockholder Written Consent), in each case, in the event that the Stockholder fails to timely perform or otherwise comply
with the covenants, agreements or obligations set forth in Section 1(a).

 

(c) The proxy granted by each Stockholder pursuant to Section 1(b) is coupled with an interest sufficient in law to support
an irrevocable proxy and is granted in consideration for Parent entering into the Merger Agreement and agreeing to consummate the transactions
contemplated thereby. The proxy granted by each Stockholder pursuant to Section 1(b) is also a durable proxy and shall survive
the bankruptcy, dissolution, death, incapacity or other inability to act by each Stockholder and shall revoke any and all prior proxies
granted by each Stockholder with respect to the Subject Company Shares. The vote or consent of the proxyholder in accordance with Section
1(b) and with respect to the matters in Section 1(a) shall control in the event of any conflict between such vote or consent
by the proxyholder of the Subject Company Shares and a vote or consent by each Stockholder of the Subject Company Shares (or any other
Person with the power to vote the Subject Company Shares) with respect to the matters in Section 1(a). The proxyholder may not
exercise the proxy granted pursuant to Section 1(b) on any matter except those provided in Section 1(a). For the avoidance
of doubt, each Stockholder may vote the Subject Company Shares on all other matters, subject to, for the avoidance of doubt, the other
applicable covenants, agreements and obligations set forth in this Agreement.

 

    2 

     

    

 

(d) 
Each Stockholder hereby (i) irrevocably and unconditionally waives any rights of appraisal, dissenter’s rights and any similar
rights relating to the Merger Agreement and the consummation by the parties of the Transactions, including the Merger, that such Stockholder
may have under applicable Law (including Section 262 of the Delaware General Corporation Law or otherwise), (ii) consents to, on behalf
of itself and each other holder of Company Preferred Stock, and irrevocably and unconditionally waives any and all rights such Stockholder
may have with respect to, the conversion of all outstanding shares of Company Preferred Stock into shares of Company Common Stock, with
such conversion to be in accordance with the terms of the Company Certificate of Incorporation and effective as of immediately prior to
the Effective Time of the Merger.

 

(e) Each Stockholder hereby irrevocably waives, on behalf of themselves and each other holder of Company Preferred Stock, its right
to certain payments upon liquidation of the Company pursuant to Article Fourth, Section B(2) of the Company Certificate of Incorporation
(if any).

 

2. 
Other Covenants and Agreements.

 

(a) 
Each Stockholder hereby agrees that, notwithstanding anything to the contrary in any such agreement, (i) each of the agreements
set forth on Schedule II hereto shall be automatically terminated and of no further force and effect (including any provisions
of any such agreement that, by its terms, survive such termination) effective as of, and subject to and conditioned upon the occurrence
of, the Closing and (ii) upon such termination neither the Company nor any of its Affiliates (including from and after the Effective Time,
PubCo and its Affiliates) shall have any further obligations or liabilities under each such agreement. Without limiting the generality
of the foregoing, each Stockholder hereby agrees to promptly execute and deliver all additional agreements, consents, documents and instruments
and take, or cause to be taken, all actions necessary or reasonably advisable in order to achieve the purpose of the preceding sentence.

 

(b) 
Each Stockholder acknowledges and agrees that Parent and the other Parent Parties are entering into the Merger Agreement in reliance
upon the Stockholder entering into this Agreement and agreeing to be bound by, and perform, or otherwise comply with, as applicable, the
agreements, covenants and obligations contained in this Agreement and but for the Stockholder entering into this Agreement and agreeing
to be bound by, and perform, or otherwise comply with, as applicable, the agreements, covenants and obligations contained in this Agreement,
Parent and the other Parent Parties would not have entered into or agreed to consummate the Transactions.

 

(c) 
On the Closing Date, each Stockholder shall deliver to Parent a duly executed copy of (i) the Voting Agreement and (ii) the Lock-Up
Agreement. On the Closing Date, each Stockholder that is an Affiliate of PubCo as of the Effective Time shall deliver to Parent a duly
executed copy of the Registration Rights Agreement.

 

(d) 
From the date hereof through the Closing Date, each institutional Stockholder (a “Corporate Stockholder”) shall
not, and shall cause each of its respective Representatives not to, directly or indirectly, (i) encourage, solicit, initiate, engage or
participate in negotiations with any Person concerning any Alternative Transaction, (ii) take any other action intended or designed to
facilitate the efforts of any Person relating to a possible Alternative Transaction or (iii) in furtherance and without limitation of
such Stockholder’s obligations pursuant to Section 1(a), approve, recommend or enter into any Alternative Transaction or
any Contract related to any Alternative Transaction. Immediately following the execution of this Agreement, each Corporate Stockholder
shall, and shall cause each of its Representatives to, terminate any existing discussions or negotiations with any Persons other than
Parent, on the one hand, or the Company, on the other hand, concerning any Alternative Transaction; provided that a Corporate Stockholder
and its Representatives may assist the Company in the Company’s existing licensing, collaboration, development and partnering discussions.
Each Corporate Stockholder shall be responsible for any acts or omissions of any of its Representatives that, if they were the acts or
omissions of such Stockholder, would be deemed a breach of such Stockholder’s obligations hereunder.

 

    3 

     

    

 

(e) If an Alternative
Proposal is communicated in writing to any Corporate Stockholder or any of their respective Representatives, such Corporate
Stockholders shall as promptly as practicable (and in any event within one (1) Business Day after receipt thereof) advise Company,
orally and in writing, of such Alternative Proposal and the material terms and conditions thereof (including any changes thereto)
and the identity of the Person making any such Alternative Proposal. Company shall promptly as practical (an in any event one (1)
Business Day after receipt thereof) advise Parent, orally and in writing, of such Alternative Proposal and the material terms and
conditions thereof (including any changes thereto) and the identity of the Person making any such Alternative Proposal and the
Corporate Stockholder that received such Alternative Proposal. The Corporate Stockholders shall keep Company informed, and Company
shall keep Parent informed, on a reasonably current basis of material developments with respect to any such Alternative
Proposal.

 

(f) 
Each Stockholder hereby agrees that the Merger shall not be considered a “Deemed Liquidation Event” under the terms
of the Company Certificate of Incorporation (as such term is defined therein) and that the Stockholders shall make such election by written
notice sent to the Company at least ten (10) days prior to the Closing Date and otherwise in accordance with the terms of the Company
Certificate of Incorporation.

 

3.  Stockholder
Representations and Warranties. Each Stockholder, severally and not jointly, represents and
warrants to Parent as follows:

 

(a) If Stockholder is not an individual, the Stockholder is a corporation, limited liability company or other applicable business entity
duly organized or formed, as applicable, validly existing and in good standing (or the equivalent thereof, if applicable, in each case,
with respect to the jurisdictions that recognize the concept of good standing or any equivalent thereof) under the Laws of its jurisdiction
of formation or organization (as applicable).

 

(b) 
If Stockholder is not an individual, the Stockholder has the requisite corporate, limited liability company or other similar power
and authority to execute and deliver this Agreement, to perform its covenants, agreements and obligations hereunder (including, for the
avoidance of doubt, those covenants, agreements and obligations hereunder that relate to the provisions of the Merger Agreement), and
to consummate the transactions contemplated hereby. The execution and delivery of this Agreement has been duly authorized by all necessary
corporate (or other similar) action on the part of such Stockholder. This Agreement has been duly and validly executed and delivered by
such Stockholder and constitutes a valid, legal and binding agreement of such Stockholder (assuming that this Agreement is duly authorized,
executed and delivered by Parent), enforceable against such Stockholder in accordance with its terms (subject to applicable bankruptcy,
insolvency, reorganization, moratorium or other Laws affecting generally the enforcement of creditors’ rights and subject to general
principles of equity).

 

(c) 
No consent, approval or authorization of, or designation, declaration or filing with, any governmental authority is required on
the part of such Stockholder with respect to such Stockholder’s execution, delivery or performance of its covenants, agreements
or obligations under this Agreement (including, for the avoidance of doubt, those covenants, agreements and obligations under this Agreement
that relate to the provisions of the Merger Agreement) or the consummation of the transactions contemplated hereby, except for any consents,
approvals, authorizations, designations, declarations, waivers or filings, the absence of which would not adversely affect the ability
of such Stockholder to perform, or otherwise comply with, any of its covenants, agreements or obligations hereunder in any material respect.

 

    4 

     

    

 

(d) 
None of the execution or delivery of this Agreement by such Stockholder, the performance by such Stockholder of any of its covenants,
agreements or obligations under this Agreement (including, for the avoidance of doubt, those covenants, agreements and obligations under
this Agreement that relate to the provisions of the Merger Agreement) or the consummation of the transactions contemplated hereby will,
directly or indirectly (with or without due notice or lapse of time or both) (i) result in any breach of any provision of such Stockholder’s
organizational documents, (ii) result in a violation or breach of, or constitute a default or give rise to any right of termination, consent,
cancellation, amendment, modification, suspension, revocation or acceleration under, any of the terms, conditions or provisions of any
Contract to which such Stockholder is a party, (iii) violate, or constitute a breach under, any Order or applicable Law to which such
Stockholder or any of its properties or assets are bound or (iv) result in the creation of any Lien upon such Stockholder’s Subject
Company Shares, except, in the case of any of clauses (ii) and (iii) directly above, as would not adversely affect
the ability of such Stockholder to perform, or otherwise comply with, any of its covenants, agreements or obligations hereunder in any
material respect.

 

(e) 
Stockholder is the record and beneficial owner of the Subject Company Shares set forth opposite such Stockholder’s name on
Schedule I hereto and has valid, good and marketable title to such Subject Company Shares, free and clear of all Liens (other than
transfer restrictions under applicable Securities Law). Except for the shares of Company Capital Stock set forth on Schedule I
hereto, together with any other shares of Company Capital Stock or other equity interests (including anything convertible into such equity
interests) of the Company of which the Stockholder acquires record or beneficial ownership after the date hereof, such Stockholder has
the sole right to vote (and provide consent in respect of, as applicable) the Subject Company Shares and, except for this Agreement, the
Merger Agreement, that certain Voting Agreement, dated January 19, 2021, that certain Investors’ Rights Agreement, dated January
19, 2021 and that certain Right of First Refusal and Co-Sale Agreement, dated January 19, 2021, such Stockholder is not party to or bound
by (i) any option, warrant, purchase right, or other Contract that would (either alone or in connection with one or more events, developments
(including the satisfaction or waiver of any conditions precedent)) require such Stockholder to Transfer (as defined below) any of the
Subject Company Shares or (ii) any voting trust, proxy or other Contract with respect to the voting or Transfer of any of the Subject
Company Shares.

 

(f)  
There is no proceeding pending or, to the Stockholder’s knowledge, threatened against such Stockholder that questions the
beneficial or record ownership of such Stockholder’s Subject Company Shares, the validity of this Agreement or the performance by
such Stockholder of its obligations under this Agreement, or which would reasonably be expected to adversely affect the ability of such
Stockholder to perform, or otherwise comply with, any of its covenants, agreements or obligations under this Agreement in any material
respect.

 

(g) 
The Stockholder, on his, her or its own behalf and on behalf of his, her or its Representatives, acknowledges, represents, warrants
and agrees that (i) he, she or it has conducted his, her or its own independent review and analysis of, and, based thereon, has formed
an independent judgment concerning, the business, assets, condition, operations and prospects of, the Parent Parties and (ii) he, she
or it has been furnished with or given access to such documents and information about the Parent Parties and their respective businesses
and operations as he, she or it and his, her or its Representatives have deemed necessary to enable him, her or it to make an informed
decision with respect to the execution, delivery and performance of this Agreement, the other Additional Agreements to which he, she or
it is or will be a party and the transactions contemplated hereby and thereby.

 

    5 

     

    

 

(h) 
In entering into this Agreement and the other Additional Agreements to which he, she or it is or will be a party, the Stockholder
has relied solely on his, her or its own investigation and analysis and the representations and warranties expressly set forth in the
Additional Agreements to which he, she or it is or will be a party and no other representations or warranties of any Parent Party (including,
for the avoidance of doubt, none of the representations or warranties of any Parent Party set forth in the Merger Agreement or any other
Additional Agreements), any Affiliate of Parent or any other Person, either express or implied, and such Stockholder, on his, her or its
own behalf and on behalf of his, her or its Representatives, acknowledges, represents, warrants and agrees that, except for the representations
and warranties expressly set forth in the Additional Agreements to which he, she or it is or will be a party, none of the Parent Parties,
any Affiliate of Parent or any other Person makes or has made any representation or warranty, either express or implied, in connection
with or related to this Agreement, the Additional Agreements to which he, she or it is or will be a party or the transactions contemplated
hereby or thereby.

 

4. 
Transfer of Subject Securities. Except as expressly contemplated by the Merger Agreement or
with the prior written consent of Parent (such consent to be given or withheld in its sole discretion), from and after the date hereof
and through the Closing of the Transactions, each Stockholder agrees not to (a) Transfer any of the Subject Company Shares, (b) enter
into (i) any option, warrant, purchase right, or other Contract that would (either alone or in connection with one or more events or developments
(including the satisfaction or waiver of any conditions precedent)) require such Stockholder to Transfer the Subject Company Shares or
(ii) any voting trust, proxy or other Contract with respect to the voting or Transfer of the Subject Company Shares, or (c) take any actions
(i) having the effect of preventing or disabling such Stockholder from performing its obligations under this Agreement or (ii) in furtherance
of any of the matters described in the foregoing clauses (a) or (b). For purposes of this Agreement, “Transfer”
means any, direct or indirect, sale, transfer, assignment, pledge, mortgage, exchange, hypothecation, grant of a security interest in
or disposition or encumbrance of an interest (whether with or without consideration, whether voluntarily or involuntarily or by operation
of law or otherwise). 

 

5. 
Termination. This Agreement shall automatically terminate, without any notice or other action
by any Party, and be void ab initio upon the earlier of (a) the Effective Time; (b) the termination of the Merger Agreement in
accordance with its terms and (c) upon the mutual written agreement of Parent and each Stockholder. Upon termination of this Agreement
as provided in the immediately preceding sentence, none of the Parties shall have any further obligations or liabilities under, or with
respect to, this Agreement. 

 

 

6. 
Fiduciary Duties. Notwithstanding anything in this Agreement to the contrary, (a) each Stockholder
makes no agreement or understanding herein in any capacity other than in such Stockholder’s capacity as a record holder and beneficial
owner of the Subject Company Shares, and not in such Stockholder’s capacity as a director, officer or employee of the Company or
any other capacity and (b) nothing herein will be construed to limit or affect any action or inaction by any Stockholder serving as a
member of the board of directors of the Company or as an officer, employee or fiduciary of the Company, in each case, acting in such person’s
capacity as a director, officer, employee or fiduciary of the Company.

 

 

7. 
Notices. All notices, requests, claims, demands and other communications hereunder shall be
in writing and shall be given (and shall be deemed to have been duly given) by delivery in person, by facsimile (having obtained electronic
delivery confirmation thereof) if applicable, e-mail (having obtained electronic delivery confirmation thereof (i.e., an electronic record
of the sender that the email was sent to the intended recipient thereof without an “error” or similar message that such email
was not received by such intended recipient)), or by registered or certified mail (postage prepaid, return receipt requested) (upon receipt
thereof) to the other Parties as follows:

 

    6 

     

    

 

If to Parent, to:

 

c/o FS Development Corp. II

900 Larkspur Landing Circle, Suite 150

Larkspur, California 94939

Attention: Jim Tananbaum

Email: Jim@foresitecapital.com

 

with a copy (which shall not constitute notice)
to:

 

White & Case LLP

1221 Avenue of the Americas

New York, New York 10020-1095

Attention: Joel L. Rubinstein, Esq.

Bryan Luchs

Email: joel.rubinstein@whitecase.com

 bryan.luchs@whitecase.com

 

If to a Stockholder, to the address specified by
such Stockholder in writing.

 

with a copy (which shall not constitute notice)
to:

 

Pardes Boisciences, Inc.

2173 Salk Ave., Suite 250, PMB #052

Carlsbad, CA 92008

Attention: Elizabeth H. Lacy, General Counsel & Corporate Secretary

Email: elacy@pardesbio.com

 

Goodwin Procter LLP

601 Marshall Street

Redwood City, CA 94063

Attention: Deepa Rich

Email: DRich@goodwinlaw.com

 

or to such other address as the Party to whom notice is given may have
previously furnished to the others in writing in the manner set forth above.

 

8. 
Entire Agreement. This Agreement, the Merger Agreement and documents referred to herein and
therein constitute the entire agreement of the Parties with respect to the subject matter of this Agreement, and supersede all prior agreements
and undertakings, both written and oral, among the Parties with respect to the subject matter of this Agreement, except as otherwise expressly
provided in this Agreement. For the avoidance of doubt, this Agreement shall not be effective or binding upon the Parent or any Stockholder
until such time as the Merger Agreement is executed by the parties thereto.

 

9. 
Amendments and Waivers; Assignment. Any provision of this Agreement may be amended or waived
if, and only if, such amendment or waiver is in writing and signed by each of Stockholder and Parent. Notwithstanding the foregoing, no
failure or delay by any Party in exercising any right hereunder shall operate as a waiver thereof nor shall any single or partial exercise
thereof preclude any other or further exercise of any other right hereunder. Neither this Agreement nor any of the rights, interests or
obligations hereunder shall be assignable by any Stockholder without Parent’s prior written consent (to be withheld or given in
its sole discretion).

 

    7 

     

    

 

10. Fees and Expenses. Except as otherwise expressly set forth in the Merger Agreement, all fees and expenses incurred in connection
with this Agreement and the transactions contemplated hereby, including the fees and disbursements of counsel, financial advisors and
accountants, shall be paid by the Party incurring such fees or expenses.

 

11. 
Remedies. Except as otherwise expressly provided herein, any and all remedies provided herein will be deemed cumulative
with and not exclusive of any other remedy conferred hereby, or by law or equity upon such Party, and the exercise by a Party of any one
remedy will not preclude the exercise of any other remedy. The Parties agree that irreparable damage for which monetary damages, even
if available, would not be an adequate remedy, would occur in the event that either Party does not perform its respective obligations
under the provisions of this Agreement in accordance with their specific terms or otherwise breach such provisions. It is accordingly
agreed that each Party shall be entitled to an injunction or injunctions, specific performance and other equitable relief to prevent breaches
of this Agreement and to enforce specifically the terms and provisions of this Agreement, in each case, without posting a bond or undertaking
and without proof of damages and this being in addition to any other remedy to which they are entitled at law or in equity. Each Party
agrees that it will not oppose the granting of an injunction, specific performance and other equitable relief when expressly available
pursuant to the terms of this Agreement on the basis that the other parties have an adequate remedy at law or an award of specific performance
is not an appropriate remedy for any reason at law or equity. No Stockholder shall be liable for the breach by any other Stockholder of
this Agreement

 

12. No Third Party Beneficiaries. This Agreement shall be for the sole benefit of the Parties
and their respective successors and permitted assigns and is not intended, nor shall be construed, to give any Person, other than the
Parties and their respective successors and assigns, any legal or equitable right, benefit or remedy of any nature whatsoever by reason
of this Agreement. Nothing in this Agreement, expressed or implied, is intended to or shall constitute the Parties, partners or participants
in a joint venture.

 

13. 
Miscellaneous. Sections 1.2 (Construction), 12.7 (Governing Law), 12.8 (Counterparts; Facsimile
Signatures) and 12.10 (Severability) of the Merger Agreement are incorporated herein by reference and shall apply to this Agreement, mutatis
mutandis.

 

[Signature page follows]

 

    8 

     

    

 

IN WITNESS WHEREOF, the Parties
have executed and delivered this Company Support Agreement as of the date first above written.

 

	 	FS DEVELOPMENT CORP.  II
	 	 	 
	 	By:	/s/ James B. Tananbaum
	 	 	Name:	James B. Tananbaum
	 	 	Title:	Chief Executive Officer

 

[Signature Page to Company Support Agreement]

 

    9 

     

    

 

	 	FORESITE CAPITAL FUND V, L.P.
	 	 
	 	By:	Foresite Capital Management V, LLC
	 	 	Its General Partner
	 	 	 	 
	 	By:	/s/ Dennis D. Ryan
	 	 	Name:	Dennis D. Ryan
	 	 	Title:	Chief Financial Officer
	 	 	 	 
	 	FORESITE CAPITAL OPPORTUNITY FUND V, L.P.
	 	 
	 	By:	Foresite Capital Opportunity Management V, LLC
	 	 	Its General Partner
	 	 	 
	 	By:	/s/ Dennis D. Ryan
	 	 	Name:	Dennis D. Ryan
	 	 	Title:	 Chief Financial Officer
	 	 	 	 
	 	GMF PARDES LLC
	 	 
	 	By:	/s/ J. Jay Lobell
	 	 	Name:	J. Jay Lobell
	 	 	Title:	Managing Member

 

[Signature Page to Company Support Agreement]

 

    10 

     

    

 

	 	KHOSLA VENTURES SEED D, LP
	 	 
	 	By: Khosla Ventures Seed Associates D, LLC, a Delaware limited liability company and general
    partner of Khosla Ventures Seed D, LP
	 	 
	 	By: 	/s/ John Demeter
	 	 	Name: 	John Demeter
	 	 	Title:	General Counsel
	 	 
	 	KHOSLA VENTURES VII, LP
	 	 
	 	By: Khosla Ventures Associates VII, LLC,, a Delaware limited liability company and general partner
    of Khosla Ventures VII, LP
	 	 
	 	By:	/s/ John Demeter
	 	 	Name:	John Demeter
	 	 	Title:	General Counsel
	 	 
	 	LOPATIN DESCENDANTS’ TRUST
	 	 
	 	By:	/s/ Uri A. Lopatin, M.D.
	 	 	Name:	Uri A. Lopatin, M.D.
	 	 	Title:	Trustee
	 	 
	 	By:	/s/ Katherine Lopatin
	 	 	Name:	Katherine Lopatin
	 	 	Title:	Trustee

 

	 	Uri A. Lopatin, M.D.
	 	 
	 	Signature: 	/s/ Uri A. Lopatin, M.D.

 

[Signature Page to Company Support Agreement]

 

    11 

     

    

 

	 	Lee D. Arnold, Ph.D.
	 	 	 
	 	Signature: 	/s/ Lee D. Arnold, Ph.D.

 

	 	Brian P. Kearney, PharmD
	 	 	 
	 	Signature: 	/s/ Brian P. Kearney, PharmD
	 	 	 
	 	Heidi Henson
	 	 	 
	 	Signature: 	/s/ Heidi Henson

 

	 	Elizabeth H. Lacy
	 	 	 
	 	Signature: 	/s/ Elizabeth H. Lacy

 

[Signature Page to Company Support Agreement]

 

    12 

     

    

 

SCHEDULE I

 

	Security Holder	 	Series A Preferred	 	 	Series A-1 Preferred	 	 	Series A-2 Preferred	 	 	Series A-3 Preferred	 	 	Common Stock	 	 	Total	 
	Khosla Ventures VII, LP	 	 	1,954,338	 	 	 	 	 	 	 	   	 	 	 	 	 	 	 	 	 	 	 	1,954,338	 
	Khosla Ventures Seed D, LP	 	 	 	 	 	 	2,415,458	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2,415,458	 
	Foresite Capital Fund V, L.P.	 	 	4,237,940	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	4,237,940	 
	Uri Lopatin	 	 	 	 	 	 	 	 	 	 	 	 	 	 	34,505	 	 	 	3,750,000	 	 	 	3,784,505	 
	Lopatin Descendants’ Trust	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	250,000	 	 	 	250,000	 
	GMF Pardes LLC	 	 	2,195,824	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2,195,824	 
	Lee Arnold	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2,000,000	 	 	 	2,000,000	 
	Foresite Capital Opportunity Fund V, L.P.	 	 	1,273,577	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	1,273,577	 
	Brian P. Kearney	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	325,000	 	 	 	325,000	 
	Heidi Henson1	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	225,000	 	 	 	225,000	 
	Elizabeth Lacy2	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	150,000	 	 	 	150,000	 

 

 

 

	1	Heidi Henson is the grantee of a stock option to purchase 171,611 shares of common stock of the Company, none of which are vested

 

	2	Elizabeth Lacy is the grantee of a stock option to purchase 150,322 shares of common stock of the Company, none of which are vested.

 

    13 

     

    

 

SCHEDULE II

 

		1.	Investors’ Rights Agreement dated January 19, 2021 by and between the Company and each of the investors listed on Schedule A
thereto.

 

		2.	Voting Agreement dated as of January 19, 2021 by and among the Company and the investors listed on Schedule A thereto and those certain
stockholders of the Company listed on Schedule B thereto.

 

		3.	Right of First Refusal and Co-Sale Agreement dated as of January 19, 2021 by and among the Company, the Investors listed on Schedule
A thereto and the Key Holders listed on Schedule B thereto.

 

		4.	Management Rights Letter dated January 21, 2021, executed by the Company and in favor of Khosla Ventures VI, L.P.

 

		5.	Series A Preferred Stock Purchase Agreement, dated as of January 19, 2021, by and among the Company and each of the investors listed
on Schedule A thereto.

 

 

14Exhibit 10.3

 

SUBSCRIPTION AGREEMENT

 

FS Development Corp. II

900 Larkspur Landing Circle, Suite 150

Larkspur, CA 94939

 

Ladies and Gentlemen:

 

In connection with the proposed
business combination (the “Transaction”) between FS Development Corp. II,
a Delaware corporation (“FSII”), and Pardes Biosciences, Inc., a Delaware
corporation (“Target”), pursuant to a merger agreement to be entered into among FSII, Target, and the other parties
thereto (the “Transaction Agreement”), FSII is seeking commitments from interested
investors to purchase shares of Class A common stock, par value $0.0001 per share (the “Shares”),
of FSII, for a purchase price of $10.00 per share (the “Per Share Purchase Price”). The aggregate purchase price to
be paid by the undersigned (the “Investor”) for the subscribed Shares (as set forth on the signature page hereto) is
referred to herein as the “Subscription Amount.” On or about the date of this Subscription Agreement, FSII is entering
into subscription agreements (the “Other Subscription Agreements” and together with this Subscription Agreement, the
“Subscription Agreements”) with certain other investors (the “Other Investors,” and together with
the Investor, the “Investors”), severally and not jointly, pursuant to which the Investors, severally and not jointly,
have agreed to purchase on the closing date of the Transaction, inclusive of the Shares subscribed for by the Investor, an aggregate amount
of up to 7,500,000 Shares, at a per share price equal to the Per Share Purchase Price.

 

In connection therewith, and
in consideration of the foregoing and the mutual representations, warranties and covenants, and subject to the conditions, set forth herein,
and intending to be legally bound hereby, the Investor and FSII agree as follows:

 

1. Subscription. The
Investor hereby irrevocably subscribes for and agrees to purchase from FSII, and FSII agrees to issue and sell to the Investor upon the
payment of the Subscription Amount, such number of Shares as is set forth on the signature page of this Subscription Agreement on the
terms and subject to the conditions provided for herein.

 

2. Closing. The
closing of the sale of the Shares contemplated hereby (the “Closing”) is contingent upon the substantially
concurrent consummation of the Transaction, as provided in the Transaction Agreement. The Closing shall occur on the date of, and
substantially concurrently with and conditioned upon the effectiveness of the Transaction and immediately after the Merger (as
defined in the Transaction Agreement). Upon (i) satisfaction or waiver of the conditions set forth in Section 3 below and
(ii) delivery of written notice from (or on behalf of) FSII to the Investor (the “Closing Notice”) that FSII
reasonably expects all conditions to the closing of the Transaction to be satisfied or waived on a date that is not less than five
(5) business days from the date on which the Closing Notice is delivered to the undersigned, the Investor shall deliver to FSII, at
least three (3) business days prior to the closing date specified in the Closing Notice (the “Closing Date”), or
such other date on or prior to the Closing Date as otherwise agreed to by FSII and the Investor, the Subscription Amount by wire
transfer of United States dollars in immediately available funds to the account(s) (which account shall not be an escrow account)
specified by FSII in the Closing Notice. On the Closing Date, FSII shall (A) issue a number of Shares to the Investor set forth on
the signature page of this Subscription Agreement and subsequently cause the Shares to be registered in book entry form, free and
clear of any liens or other restrictions (other than those arising under applicable securities laws) in the name of the Investor (or
its nominees in accordance with its delivery instructions) or to a custodian designated by the Investor, as applicable, on
FSII’s share register and (B) provide evidence from FSII’s transfer agent of the issuance to the Investor of such Shares
on and as of the Closing Date; provided, however, that FSII’s obligation to issue the Shares to the Investor is
contingent upon FSII having received the Subscription Amount in full in accordance with this Section 2. Notwithstanding the
foregoing, for any Investor that informs FSII (1) that it is an investment company registered under the Investment Company Act of
1940, as amended, (2) that it is advised by an investment adviser subject to regulation under the Investment Advisers Act of 1940,
as amended or (3) that its internal compliance policies and procedures so require it, then, in lieu of the settlement procedures in
the foregoing two sentences, the following shall apply: such Investor shall deliver at 8:00 a.m. New York City time on the Closing
Date (or as soon as practicable following receipt of evidence from FSII’s transfer agent of the issuance to such Investor of
the Shares on and as of the Closing Date) the Subscription Amount for such Shares by wire transfer of United States dollars in
immediately available funds to the account (s) (which account shall not be an escrow account) specified by FSII in the Closing
Notice against delivery by FSII to such Investor of such Shares in book entry form, free and clear of any liens or other
restrictions (other than those arising under applicable securities laws), in the name of such Investor (or its nominees in
accordance with its delivery instructions) or to a custodian designated by such Investor, as applicable, on FSII’s share
register and evidence from FSII’s transfer agent of the issuance to such Investor of such Shares on and as of the Closing Date.
If the Closing of the Transaction does not occur within three (3) business days after the Closing Date, FSII shall promptly (but no
later than three (3) business days after the Closing Date) return the funds so delivered by the Investor to FSII by wire transfer in
immediately available funds to the account specified by the Investor. For purposes of this Subscription Agreement, “business
day” shall mean any day other than (a) any Saturday or Sunday or (b) any other day on which commercial banks in New York, New
York and San Diego, California are open for the general transaction of business.

 

    1

     

    

 

3. Closing Conditions.

 

a. The obligation of the parties
hereto to consummate the purchase and sale of the Shares pursuant to this Subscription Agreement is subject to the following conditions:

 

(i) no applicable
governmental authority shall have enacted, issued, promulgated, enforced or entered any judgment, order, law, rule or regulation (whether
temporary, preliminary or permanent) which is then in effect and has the effect of making consummation of the transactions contemplated
hereby illegal or otherwise restraining or prohibiting consummation of the transactions contemplated hereby;

 

(ii) no suspension
of the qualification of the Shares for offering or sale or trading on the Stock Exchange (as defined below) or, to FSII’s knowledge,
initiation or threatening of any proceedings for any such purpose, shall have occurred prior to the Closing;

 

(iii) (A) all conditions
precedent to the closing of the Transaction shall have been satisfied (as determined by the parties to the Transaction Agreement) or waived
(other than those conditions which, by their nature, are to be satisfied at the closing of the Transaction) and (B) the closing of the
Transaction shall be scheduled to occur concurrently with or on the same date as the Closing; and

 

(iv) the Shares shall
have been approved for listing on the Stock Exchange.

 

b. The obligation of FSII to
consummate the issuance and sale of the Shares pursuant to this Subscription Agreement shall be subject to the conditions that (i) all
representations and warranties of the Investor contained in this Subscription Agreement are true and correct in all material respects
(other than representations and warranties that are qualified as to materiality or Material Adverse Effect (as defined herein), which
representations and warranties shall be true and correct in all respects) at and as of the Closing Date (except for those representations
and warranties that speak as of a specified earlier date, which shall be so true and correct as of such specified earlier date), and consummation
of the Closing shall constitute a reaffirmation by the Investor of each of the representations warranties, covenants and agreements of
the Investor contained in this Subscription Agreement in all material respects (other than those representations, warranties, covenants
and agreements of the Investor that are qualified by materiality, which shall be considered reaffirmed by the Investor in all respects)
as of the Closing Date; and (ii) the Investor shall have performed, satisfied and complied in all material respects with all covenants,
agreements and conditions required by the Subscription Agreement to be performed, satisfied or complied with by it at or prior to the
Closing.

 

c. The obligation of the Investor
to consummate the purchase of the Shares pursuant to this Subscription Agreement shall be subject to the conditions that (i) all representations
and warranties of FSII contained in this Subscription Agreement shall be true and correct in all material respects (other than representations
and warranties that are qualified as to materiality or Material Adverse Effect (as defined herein), which representations and warranties
shall be true and correct in all respects) at and as of the Closing Date (except for those representations and warranties that speak as
of a specified earlier date, which shall be so true and correct as of such specified earlier date), and consummation of the Closing shall
constitute a reaffirmation by FSII of each of the representations, warranties, covenants and agreements of FSII contained in this Subscription
Agreement in all material respects other than those representations, warranties, covenants and agreements of FSII that are qualified by
materiality, which shall be considered reaffirmed by FSII in all respects as of the Closing Date; (ii) FSII shall have performed, satisfied
and complied in all material respects with all covenants, agreements and conditions required by the Subscription Agreement to be performed,
satisfied or complied with by it at or prior to the Closing; (iii) the terms of the Transaction Agreement shall not have been amended,
modified or waived in a manner that would reasonably be expected to materially and adversely affect the economic benefits that the Investor
would reasonably expect to receive under this Subscription Agreement; and (iv) there shall have been no amendment, waiver or modification
to the Other Subscription Agreements that materially economically benefits the Other Investors thereunder unless the Investor has been
offered substantially the same benefits.

 

    2

     

    

 

4. Further Assurances.
At or prior to the Closing, the parties hereto shall execute and deliver such additional documents and take such additional actions as
the parties reasonably may deem to be practical and necessary in order to consummate the subscription as contemplated by this Subscription
Agreement.

 

5. FSII Representations
and Warranties. FSII represents and warrants to the Investor, as of the date hereof and as of the Closing Date, that:

 

a. FSII has been duly incorporated,
validly existing and in good standing under the laws of the State of Delaware, with corporate power and authority to own, lease and operate
its properties and conduct its business as presently conducted and to enter into, deliver and perform its obligations under this Subscription
Agreement.

 

b. As of the Closing Date, the
Shares will be duly authorized and, when issued and delivered to the Investor against full payment therefor in accordance with the terms
of this Subscription Agreement, the Shares will be validly issued, fully paid and non-assessable and will not have been issued in violation
of or subject to any preemptive or similar rights created under FSII’s certificate of incorporation (as amended to the Closing Date)
or under the laws of the State of Delaware.

 

c. This Subscription Agreement
has been duly authorized, executed and delivered by FSII and, assuming that this Subscription Agreement constitutes the valid and binding
agreement of the Investor, this Subscription Agreement constitutes the valid and binding agreement of FSII and is enforceable against
FSII in accordance with its terms, except as may be limited or otherwise affected by bankruptcy, insolvency, reorganization or other similar
laws affecting the enforcement of creditors’ rights generally and by general principles of equity.

 

d. The execution and delivery
of this Subscription Agreement, the issuance and sale of the Shares and the compliance by FSII with all of the provisions of this Subscription
Agreement and the consummation of the transactions contemplated herein will not (i) conflict with or result in a breach or violation of
any of the terms or provisions of, or constitute a default under, or result in the creation or imposition of any lien, charge or encumbrance
upon any of the property or assets of FSII or any of its subsidiaries pursuant to the terms of any indenture, mortgage, deed of trust,
loan agreement, lease, license or other agreement or instrument to which FSII or any of its subsidiaries is a party or by which FSII or
any of its subsidiaries is bound or to which any of the property or assets of FSII is subject that would reasonably be expected to have
a material adverse effect on the business, financial condition or results of operations of FSII and its subsidiaries, taken as a whole
(a “Material Adverse Effect”) or materially and adversely affect the ability of FSII to consummate the Transaction,
the validity of the Shares or the legal authority of FSII to comply in all material respects with the terms of this Subscription Agreement;
(ii) result in any violation of the provisions of the organizational documents of FSII; or (iii) result in any violation of any statute
or any judgment, order, rule or regulation of any court or governmental agency or body, domestic or foreign, having jurisdiction over
FSII or any of their properties that would reasonably be expected to have a Material Adverse Effect or materially and adversely affect
the validity of the Shares or the legal authority of FSII to comply in all material respects with this Subscription Agreement.

 

e. As of their respective dates,
all filings, registration statements, proxy statements, reports and other documents (the “SEC Reports”) required to
be filed by FSII with the U.S. Securities and Exchange Commission (the “SEC”) complied in all material respects with
the applicable requirements of the Securities Act of 1933, as amended (the “Securities Act”), and the Securities Exchange
Act of 1934, as amended (the “Exchange Act”) and the rules and regulations of the SEC promulgated thereunder, and none
of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated
therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. 
The financial statements of FSII included in the SEC Reports comply in all material respects with applicable accounting requirements and
the rules and regulations of the SEC with respect thereto as in effect at the time of filing and fairly present in all material respects
the financial condition of FSII as of and for the dates thereof and the results of operations and cash flows for the periods then ended,
subject, in the case of unaudited statements, to normal, year-end audit adjustments. A copy of each SEC Report is available to the Investor
via the SEC’s EDGAR system. There are no outstanding or unresolved comments in comment letters received by FSII from the staff of
the Division of Corporation Finance of the SEC with respect to any of the SEC Reports.

 

    3

     

    

 

f. FSII has not entered into
any side letter or similar agreement with any Other Investor or any other investor in connection with such Other Investor’s or other
investor’s direct or indirect investment in FSII other than the Other Subscription Agreements, the Transaction Agreement, any letters
or agreements relating to board observer rights, or any agreement with FS Development Holdings II, LLC, or any affiliate thereof, to purchase
Shares in connection with the backstop of any redemptions by any of FSII’s public stockholders (“Public Stockholders”)
of their Shares. No Other Subscription Agreement contains terms (economic or otherwise) more favorable to such Other Investor or investor
than as set forth in this Subscription Agreement. The Other Subscription Agreements have not been amended in any material respect following
the date of this Subscription Agreement.

 

g. FSII is not required to obtain
any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal,
state, local or other governmental authority, self-regulatory organization or other person in connection with the execution, delivery
and performance by FSII of this Subscription Agreement (including, without limitation, the issuance of the Shares), other than (i) filings
with the SEC, (ii) filings required by applicable state securities laws, (iii) filings required by The Nasdaq Capital Market, or such
other applicable stock exchange on which the Shares are then listed (the “Stock Exchange”) and (iv) the failure of
which to obtain would not be reasonably likely to have, individually or in the aggregate, a Material Adverse Effect. FSII is in compliance
with all applicable laws and rules of The Nasdaq Capital Market.

 

h. As of the date of this Subscription
Agreement, the authorized capital stock of FSII consists of 100,000,000 Shares of which 20,727,500 are outstanding, 10,000,000 shares
of Class B common stock, par value $0.0001 per share of which 5,031,250 are issued and outstanding, and 1,000,000 shares of preferred
stock, par value $0.0001 per share, none of which are issued and outstanding. No other shares of capital stock or other voting securities
of FSII are issued, reserved for issuance or outstanding. All issued and outstanding Shares are duly authorized, validly issued, fully
paid and nonassessable and not subject to or issued in violation of any purchase option, right of first refusal, preemptive right, subscription
right or any similar right under any provision of the Delaware General Corporation Law, FSII’s organizational documents or any contract
to which FSII is a party or by which FSII is bound. Except as set forth in FSII’s organizational documents, there are no outstanding
contractual obligations of FSII to repurchase, redeem or otherwise acquire any Shares or any capital equity of FSII. Except as set forth
in FSII’s certificate of incorporation, there are no securities or instruments issued by or to which FSII is a party containing
anti-dilution or similar provisions that will be triggered by the issuance of (i) the Shares pursuant to this Subscription Agreement or
(ii) the shares to be issued pursuant to any Other Subscription Agreement. There are no outstanding contractual obligations of FSII to
provide funds to, or make any investment (in the form of a loan, capital contribution or otherwise) in, any other person or entity.

 

i. The issued and outstanding
Shares are registered pursuant to Section 12(b) of the Exchange Act, and are listed for trading on the Stock Exchange. As of the
date hereof, there is no suit, action, proceeding or investigation pending or, to the knowledge of FSII, threatened against FSII by the
Stock Exchange or the SEC, respectively, to prohibit or terminate the listing of the Shares on the Stock Exchange or to deregister the
Shares under the Exchange Act. FSII has taken no action that is designed to terminate the registration of the Shares under the Exchange
Act.

 

j. Assuming the accuracy of
the Investor’s representations and warranties set forth in Section 6, no registration under the Securities Act is required
for the offer and sale of the Shares by FSII to the Investor hereunder. The Shares (i) were not offered by any form of general solicitation
or general advertising and (ii) are not being offered in a manner involving a public offering under, or in a distribution in violation
of, the Securities Act, or any state securities laws.

 

k. Except for such matters as
have not had and would not be reasonably likely to have, individually or in the aggregate, a Material Adverse Effect, there is no (i)
action, suit, claim or other proceeding, in each case by or before any governmental authority pending, or, to the knowledge of FSII, threatened
against FSII or (ii) judgment, decree, injunction, ruling or order of any governmental entity or arbitrator outstanding against FSII.

 

    4

     

    

 

l. FSII has not received any
written communication from a governmental authority that alleges that FSII is not in compliance with or is in default or violation of
any applicable law, except where such non-compliance, default or violation would not reasonably be expected to have a Material Adverse
Effect.

 

m. Other than the Placement
Agents (as defined below), FSII has not engaged any broker, finder, commission agent, placement agent or arranger in connection with the
sale of the Shares, and FSII is not under any obligation to pay any broker’s fee or commission in connection with the sale of the
Shares hereunder other than to the Placement Agents.

 

n. FSII acknowledges and agrees
that, notwithstanding anything herein to the contrary, the Shares may be pledged by Investor in connection with a bona fide margin agreement,
provided such pledge shall be (i) pursuant to an available exemption from the registration requirements of the Securities Act or (ii)
pursuant to, and in accordance with, a registration statement that is effective under the Securities Act at the time of such pledge, and
the Investor effecting a pledge of Shares shall not be required to provide FSII with any notice thereof; provided, however,
that neither FSII, Target or their respective counsels shall be required to take any action (or refrain from taking any action) in connection
with any such pledge.

 

o. FSII is not, and immediately
after receipt of payment for the Shares, will not be, an “investment company” within the meaning of the Investment Company
Act of 1940, as amended.

 

6. Investor Representations
and Warranties. The Investor represents and warrants to FSII that:

 

a. The Investor (i) is a “qualified
institutional buyer” (as defined in Rule 144A under the Securities Act), an institutional “accredited investor” or an
“accredited investor” (within the meaning of Rule 501(a) under the Securities Act), in each case, satisfying the applicable
requirements set forth on Schedule A, (ii) is an “institutional account” (as defined in FINRA Rule 4512(c)), (iii)
is not an underwriter (as defined in Section 2(a)(11) of the Securities Act) and is acquiring the Shares only for his, her or its own
account and not for the account of others, or if the undersigned is subscribing for the Shares as a fiduciary or agent for one or more
investor accounts, the Investor has full investment discretion with respect to each such account, and the full power and authority to
make the acknowledgements, representations and agreements herein on behalf of each owner of each such account and (iv) is not acquiring
the Shares with a view to, or for offer or sale in connection with, any distribution thereof in violation of the Securities Act (and shall
provide the requested information on Schedule A). The Investor is not an entity formed for the specific purpose of acquiring the
Shares.

 

b. The Investor
understands that the Shares are being offered in a transaction not involving any public offering within the meaning of the
Securities Act and that the Shares have not been registered under the Securities Act. The Investor understands that the Shares may
not be resold, transferred, pledged or otherwise disposed of by the Investor absent an effective registration statement under the
Securities Act except (i) to FSII or a subsidiary thereof, (ii) to non-U.S. persons pursuant to offers and sales that occur outside
the United States within the meaning of Regulation S under the Securities Act or (iii) pursuant to another applicable exemption from
the registration requirements of the Securities Act, and in each of cases in clauses (i) and (iii), in accordance with any applicable
securities laws of the states and other jurisdictions of the United States, and that any certificates representing the Shares shall
contain a restrictive legend to such effect. The Investor acknowledges that the Shares will not be eligible for resale pursuant to
Rule 144A promulgated under the Securities Act. The Investor understands and agrees that the Shares will be subject to transfer
restrictions and, as a result of these transfer restrictions, the Investor may not be able to readily offer, resell, transfer,
pledge or otherwise dispose of the Shares and may be required to bear the financial risk of an investment in the Shares for an
indefinite period of time. The Investor acknowledges and agrees that the Shares will not be eligible for offer, resale, transfer,
pledge or disposition pursuant to Rule 144 promulgated under the Securities Act until at least one year from the date that FSII
files a Current Report on Form 8-K following the Closing Date that includes the “Form 10” information required under
applicable SEC rules and regulations. The Investor understands that it has been advised to consult legal counsel prior to making any
offer, resale, transfer, pledge or disposition of any of the Shares.

 

c. The Investor understands
and agrees that the Investor is purchasing the Shares from FSII. The Investor further acknowledges that there have been no representations,
warranties, covenants and agreements made to the Investor by FSII, Target or their respective officers or directors, expressly or by implication,
other than those representations, warranties, covenants and agreements included in this Subscription Agreement.

 

    5

     

    

 

d. The Investor’s acquisition
and holding of the Shares will not constitute or result in a non-exempt prohibited transaction under Section 406 of the Employee Retirement
Income Security Act of 1974, as amended, Section 4975 of the Internal Revenue Code of 1986, as amended, or any applicable similar law.

 

e. The Investor acknowledges
and agrees that the Investor has received such information as the Investor deems necessary in order to make an investment decision with
respect to the Shares, including with respect to FSII, Target or the Transaction. Without limiting the generality of the foregoing, the
Investor acknowledges that it has reviewed the SEC Reports and any disclosure documents used in the offering of the Shares. The Investor
represents and agrees that the Investor and the Investor’s professional advisor(s), if any (i) have had the full opportunity to
ask such questions, receive such answers and obtain such information as the Investor and such Investor’s professional advisor(s),
if any, have deemed necessary to make an investment decision with respect to the Shares and (ii) have independently made their own analysis
and decision to invest in FSII.

 

f. The Investor became aware
of this offering of the Shares solely by means of direct contact between the Investor and FSII, Target, or a representative of FSII or
Target, including the Placement Agents, and the Shares were offered to the Investor solely by direct contact between the Investor and
FSII, Target, or a representative of FSII or Target. The Investor did not become aware of this offering of the Shares, nor were the Shares
offered to the Investor, by any other means. The Investor acknowledges that the Shares (i) were not offered by any form of general solicitation
or general advertising and (ii) are not being offered in a manner involving a public offering under, or in a distribution in violation
of, the Securities Act, or any state securities laws. Investor acknowledges that it is not relying upon, and has not relied upon, any
statement, representation or warranty made by any person, firm or corporation (including, without limitation, Target, FSII, Jefferies
LLC or SVB Leerink LLC (each a “Placement Agent”, and together, the “Placement
Agents”) or their respective affiliates or any of their or their respective affiliates’ control persons, officers,
directors, employees or representatives), other than the representations and warranties of FSII contained in Section 5 of this Subscription
Agreement, in making its investment or decision to invest in FSII.

 

g. The Investor acknowledges
that it is aware that there are substantial risks incident to the purchase and ownership of the Shares, including those set forth in FSII’s
filings with the SEC. The Investor has such knowledge and experience in financial and business matters as to be capable of evaluating
the merits and risks of an investment in the Shares, and the Investor has sought such accounting, legal and tax advice as the Investor
has considered necessary to make an informed investment decision.

 

h. Alone, or together with any
professional advisor(s), the Investor has adequately analyzed and fully considered the risks of an investment in the Shares and determined
that the Shares are a suitable investment for the Investor and that the Investor is able at this time and in the foreseeable future to
bear the economic risk of a total loss of the Investor’s investment in FSII. The Investor acknowledges specifically that a possibility
of total loss exists.

 

i. Investor acknowledges and
agrees that neither of the Placement Agents, nor any affiliate of the Placement Agents, has provided Investor with any information or
advice with respect to the Shares nor is such information or advice necessary or desired. Neither of the Placement Agents nor any of their
respective affiliates has made or makes any representation as to FSII, Target or the quality or value of the Shares and the Placement
Agents and any of their respective affiliates may have acquired non-public information with respect to FSII or Target which Investor agrees
need not be provided to it. In making its decision to purchase the Shares, the Investor has relied solely upon independent investigation
made by the Investor. Without limiting the generality of the foregoing, the Investor has not relied on any statements or other information
provided by or on behalf of the Placement Agents or any of their respective affiliates or any of their or their respective affiliates’
control persons, officers, directors, employees or representatives concerning FSII, Target, the Transaction, the Transaction Agreement,
this Subscription Agreement or the transactions contemplated hereby or thereby, the Shares or the offer and sale of the Shares.

 

    6

     

    

 

j. The Investor understands
and agrees that no federal or state agency has passed upon or endorsed the merits of the offering of the Shares or made any findings or
determination as to the fairness of this investment.

 

k. The Investor has been duly
formed or incorporated and is validly existing in good standing under the laws of its jurisdiction of incorporation or formation, with
power and authority to enter into, deliver and perform its obligations under this Subscription Agreement.

 

l. The execution, delivery and
performance by the undersigned of this Subscription Agreement are within the powers of the Investor, have been duly authorized and will
not constitute or result in a breach or default under or conflict with any order, ruling or regulation of any court or other tribunal
or of any governmental commission or agency, or any agreement or other undertaking, to which the undersigned is a party or by which the
undersigned is bound, and, if the undersigned is not an individual, will not violate any provisions of the undersigned’s charter
documents, including, without limitation, its incorporation or formation papers, bylaws, indenture of trust or partnership or operating
agreement, as may be applicable. The signature of the Investor on this Subscription Agreement is genuine, and the signatory, if the Investor
is an individual, has legal competence and capacity to execute the same or, if the Investor is not an individual, the signatory has been
duly authorized to execute the same, and assuming that this Subscription Agreement constitutes the valid and binding obligation of FSII,
this Subscription Agreement constitutes a legal, valid and binding obligation of the Investor, enforceable against the undersigned in
accordance with its terms except as may be limited or otherwise affected by bankruptcy, insolvency, reorganization or other similar laws
affecting the enforcement of creditors’ rights generally and by general principles of equity.

 

m. The undersigned is not (i)
a person or entity named on the List of Specially Designated Nationals and Blocked Persons administered by the U.S. Treasury Department’s
Office of Foreign Assets Control (“OFAC”) or in any Executive Order issued
by the President of the United States and administered by OFAC (“OFAC List”),
or a person or entity prohibited by any OFAC sanctions program, (ii) a Designated National as defined in the Cuban Assets Control Regulations,
31 C.F.R. Part 515 or (iii) a non-U.S. shell bank or providing banking services indirectly to a non-U.S. shell bank. The Investor agrees
to provide law enforcement agencies, if requested thereby, such records as required by applicable law, provided that the Investor is permitted
to do so under applicable law. If the Investor is a financial institution subject to the Bank Secrecy Act (31 U.S.C. Section 5311 et seq.)
(the “BSA”), as amended by the USA PATRIOT Act of 2001 (the “PATRIOT
Act”), and its implementing regulations (collectively, the “BSA/PATRIOT Act”),
the Investor maintains policies and procedures reasonably designed to comply with applicable obligations under the BSA/PATRIOT Act. To
the extent required, it maintains policies and procedures reasonably designed for the screening of its investors against the OFAC sanctions
programs, including the OFAC List. To the extent required by applicable law, the Investor maintains policies and procedures reasonably
designed to ensure that the funds held by the Investor and used to purchase the Shares were legally derived.

 

n. No disclosure or offering
document has been prepared by either of the Placement Agents or any of their respective affiliates in connection with the offer and sale
of the Shares.

 

o. Neither the Placement Agents
nor any of their respective affiliates, directors, officers, employees, representatives and controlling persons have made any independent
investigation with respect to FSII, Target, or the Shares or the accuracy, completeness or adequacy of any information supplied to the
Investor by FSII.

 

p. In connection with the issue
and purchase of the Shares, neither of the Placement Agents nor any of their respective affiliates has acted as the Investor’s financial
advisor or fiduciary.

 

q. The
Investor has or has commitments to have, and at the Closing will have, sufficient funds to pay the Subscription Amount and consummate
the purchase and sale of the Shares when required pursuant to this Subscription Agreement.

 

r. The
Investor acknowledges that it is aware that the Placement Agents are acting as FSII’s placement agents or financial advisors and
certain of the Placement Agents are acting as financial advisor to Target in connection with the Transaction.

 

    7

     

    

 

s. If Investor is an individual,
Investor hereby understands and acknowledges that none of SVB Leerink LLC, Jefferies LLC,
or any of their respective affiliates is acting as a placement agent in connection with the offer and sale of the Shares to Investor.

 

7. Registration Rights.

 

a. In the event that the Shares
are not registered in connection with the consummation of the Transaction, FSII agrees that, within thirty (30) calendar days after the
consummation of the Transaction, it will file with the SEC (at its sole cost and expense) a registration statement registering the resale
of such Shares (the “Registration Statement”), and it shall use its commercially
reasonable efforts to have the Registration Statement declared effective as soon as practicable after the filing thereof but no later
than the earlier of (i) ninety (90) calendar days (or one hundred-twenty (120) calendar days if the SEC notifies FSII that it will “review”
the Registration Statement) following the Closing Date and (ii) ten (10) business days after FSII is notified in writing by the SEC that
the Registration Statement will not be “reviewed” or will not be subject to further review. FSII agrees to cause such Registration
Statement, or another shelf registration statement that includes the Shares to be sold pursuant to this Subscription Agreement, to remain
effective, except for such times as FSII is permitted hereunder to suspend the use of the prospectus forming part of the Registration
Statement, until the earliest of (i) the third anniversary of the Closing, (ii) the date on which the Investor ceases to hold any Shares
issued pursuant to this Subscription Agreement or (iii) on the first date on which the Investor can sell all of its Shares issued pursuant
to this Subscription Agreement (or shares received in exchange therefor) under Rule 144 of the Securities Act without volume or manner
of sale limitations and without the requirement for FSII to be in compliance with the current public information required under Rule 144(c)(2)
(or Rule 144(i)(2), if applicable). The Investor agrees to disclose its beneficial ownership as determined in accordance with Rule 13d-3
of the Exchange Act to FSII upon request to assist it in making the determination described above. In no event shall the Investor be identified
as a statutory underwriter in the Registration Statement unless requested by the SEC; provided, that if the SEC requests that
the Investor be identified as a statutory underwriter in the Registration Statement, the Investor will have an opportunity to withdraw
its Shares from the Registration Statement. Notwithstanding the foregoing, if the SEC prevents FSII from including any or all of the shares
proposed to be registered under the Registration Statement due to limitations on the use of Rule 415 of the Securities Act for the resale
of the Shares by the applicable shareholders or otherwise, such Registration Statement shall register for resale such number of Shares
which is equal to the maximum number of Shares as is permitted by the SEC. In such event, the number of Shares to be registered for each
selling shareholder named in the Registration Statement shall be reduced pro rata among all such selling shareholders. For as long as
the Registration Statement shall remain effective pursuant to this Section 7(a), FSII will use commercially reasonable efforts
to (1) qualify the Shares for listing on the Stock Exchange and (2) update or amend the Registration Statement as necessary to include
the Shares. For as long as the Investor holds the Shares, FSII will use commercially reasonable efforts to (A) make and keep public information
available, as those terms are understood and defined in Rule 144, (B) file in a timely manner all reports and other documents with the
SEC required under the Exchange Act, as long as FSII remains subject to such requirements and (C) provide all customary and reasonable
cooperation, necessary, in each case, to enable the undersigned to resell the Shares pursuant to the Registration Statement or Rule 144
of the Securities Act (when Rule 144 of the Securities Act becomes available to the Investor), as applicable. Notwithstanding anything
to the contrary contained herein, FSII may delay or postpone filing of such Registration Statement, and from time to time require the
Investor not to sell under the Registration Statement or suspend the use or effectiveness of any such Registration Statement, if the board
of directors of FSII determines in good faith that either in order for the Registration Statement to not contain a material misstatement
or omission, an amendment thereto would be needed, or if such filing or use could materially affect a bona fide business or financing
transaction of FSII or would require premature disclosure of information that could materially adversely affect FSII (each such circumstance,
a “Suspension Event”); provided, that, (I) FSII shall not so delay filing or so suspend the use of the Registration
Statement on more than two (2) occasions or for a period of more than ninety (90) consecutive days or more than a total of one hundred-twenty
(120) calendar days, in each case in any three hundred sixty (360) day period and (II) FSII shall use commercially reasonable efforts
to make such Registration Statement available for the sale by the undersigned of such securities as soon as practicable thereafter. If
so directed by FSII, the Investor will deliver to FSII or, in the Investor’s sole discretion destroy, all copies of the prospectus
covering the Shares in the Investor’s possession; provided, however, that this obligation to deliver or destroy all
copies of the prospectus covering the Shares shall not apply (i) to the extent the Investor is required to retain a copy of such prospectus
(A) in order to comply with applicable legal or regulatory requirements or (B) in accordance with a bona fide pre-existing document retention
policy or (ii) to copies stored electronically on archival servers as a result of automatic data back-up. FSII’s obligations to
include the Shares issued pursuant to this Subscription Agreement (or shares issued in exchange therefor) for resale in the Registration
Statement are contingent upon the Investor furnishing in writing to FSII such information regarding the Investor, the securities of FSII
held by the Investor and the intended method of disposition of such Shares as shall be reasonably requested by FSII to effect the registration
of such Shares, and shall execute such documents in connection with such registration as FSII may reasonably request that are customary
of a selling stockholder in similar situations, including providing that FSII shall be entitled to postpone and suspend the effectiveness
or use of the Registration Statement during any customary blackout period or similar period or as permitted hereunder. Investor shall
not be entitled to use the Registration Statement for an underwritten offering. For purposes of clarification, any failure by FSII to
timely file the Registration Statement or to have such Registration Statement declared effective pursuant to this Section 7(a)
shall not otherwise relieve FSII of its obligations to file or effect the Registration Statement set forth in this Section 7.

 

    8

     

    

 

b. At its expense FSII shall
advise the Investor within two (2) business days: (i) when a Registration Statement or any post-effective amendment thereto has become
effective; (ii) of the issuance by the SEC of any stop order suspending the effectiveness of any Registration Statement or the initiation
of any proceedings for such purpose; (iii) of the receipt by FSII of any notification with respect to the suspension of the qualification
of the Shares included therein for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose;
and (iv) subject to the provisions in this Subscription Agreement, of the occurrence of any event that requires the making of any changes
in any Registration Statement or prospectus so that, as of such date, the statements therein are not misleading and do not omit to state
a material fact required to be stated therein or necessary to make the statements therein (in the case of a prospectus, in the light of
the circumstances under which they were made) not misleading. Upon receipt of any written notice from FSII (which notice shall not contain
any material non-public information regarding FSII) of the happening of any of the foregoing or of a Suspension Event during the period
that the Registration Statement is effective or if as a result of a Suspension Event the Registration Statement or related prospectus
contains any untrue statement of a material fact or omits to state any material fact required to be stated therein or necessary to make
the statements therein, in light of the circumstances under which they were made (in the case of the prospectus) not misleading, the undersigned
agrees that (1) it will immediately discontinue offers and sales of the Shares under the Registration Statement (excluding, for the avoidance
of doubt, sales conducted pursuant to Rule 144) until the undersigned receives copies of a supplemental or amended prospectus (which FSII
agrees to promptly prepare) that corrects the misstatement(s) or omission(s) referred to above and receives notice that any post-effective
amendment has become effective or unless otherwise notified by FSII that it may resume such offers and sales and (2) it will maintain
the confidentiality of any information included in such written notice delivered by FSII except (A) for disclosure to the Investor’s
employees, agents and professional advisers who need to know such information and are obligated to keep it confidential, (B) for disclosures
to the extent required in order to comply with reporting obligations to its limited partners who have agreed to keep such information
confidential and (C) as required by law or subpoena.  FSII shall use its commercially reasonable efforts to obtain the withdrawal
of any order suspending the effectiveness of any Registration Statement as soon as reasonably practicable.  Upon the occurrence of
any event contemplated in clauses (i) through (iv) above, except for such times as FSII is permitted hereunder to suspend, and has suspended,
the use of a prospectus forming part of a Registration Statement, FSII shall use its commercially reasonable efforts to as soon as reasonably
practicable prepare a post-effective amendment to such Registration Statement or a supplement to the related prospectus, or file any other
required document so that, as thereafter delivered to purchasers of the Shares included therein, such prospectus will not include any
untrue statement of a material fact or omit to state any material fact necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading.

 

c. Indemnification.

 

(i) FSII agrees to
indemnify and hold harmless, to the extent permitted by law, the Investor, its directors, officers, employees, advisors and agents, and
each person who controls the Investor (within the meaning of the Securities Act or the Exchange Act) from and against any and all losses,
claims, damages, liabilities, costs and expenses (including, without limitation, reasonable attorneys’ fees) (collectively, “Losses”)
that arise out of or are caused by any untrue or alleged untrue statement of a material fact contained in any Registration Statement,
prospectus included in any Registration Statement (“Prospectus”) or preliminary Prospectus or any amendment thereof
or supplement thereto or any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements
therein not misleading, except insofar as the same are caused by or contained in any information furnished in writing to FSII by or on
behalf of the Investor expressly for use therein.

 

    9

     

    

 

(ii) The Investor
agrees, severally and not jointly with any other person that is a party to the Other Subscription Agreements, to indemnify and hold harmless
FSII, its directors, officers, employees, advisors and agents, and each person who controls FSII (within the meaning of the Securities
Act) from and against any and all Losses that arise out of or are caused by any untrue or alleged untrue statement of a material fact
contained in any Registration Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement thereto or any omission
or alleged omission of a material fact required to be stated therein or necessary to make the statements therein not misleading, but only
to the extent that such untrue statement or omission is contained in any information or affidavit so furnished in writing by the Investor
expressly for use therein. In no event shall the liability of the Investor be greater in amount than the dollar amount of the net proceeds
received by such Investor upon the sale of the Shares purchased pursuant to this Subscription Agreement giving rise to such indemnification
obligation.

 

(iii) Any person entitled
to indemnification herein shall (1) give prompt written notice to the indemnifying party of any claim with respect to which it seeks indemnification
(provided that the failure to give prompt notice shall not impair any person’s right to indemnification hereunder to the extent
such failure has not prejudiced the indemnifying party) and (2) permit such indemnifying party to assume the defense of such claim with
counsel reasonably satisfactory to the indemnified party. If such defense is assumed, the indemnifying party shall not be subject to any
liability for any settlement made by the indemnified party without its consent. An indemnifying party who elects not to assume the defense
of a claim shall not be obligated to pay the fees and expenses of more than one counsel for all parties indemnified by such indemnifying
party with respect to such claim, unless in the reasonable judgment of legal counsel to any indemnified party a conflict of interest exists
between such indemnified party and any other of such indemnified parties with respect to such claim. No indemnifying party shall, without
the consent of the indemnified party, consent to the entry of any judgment or enter into any settlement which cannot be settled in all
respects by the payment of money (and such money is so paid by the indemnifying party pursuant to the terms of such settlement) or which
settlement does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release
from all liability in respect to such claim or litigation.

 

(iv) The indemnification
provided for under this Subscription Agreement shall remain in full force and effect regardless of any investigation made by or on behalf
of the indemnified party or any officer, director, employee, agent, affiliate or controlling person of such indemnified party and shall
survive the transfer of the Shares purchased pursuant to this Subscription Agreement.

 

(v) If the indemnification
provided under this Section 7(c) from the indemnifying party is unavailable or insufficient to hold harmless an indemnified party
in respect of any Losses referred to herein, then the indemnifying party, in lieu of indemnifying the indemnified party, shall contribute
to the amount paid or payable by the indemnified party as a result of such Losses in such proportion as is appropriate to reflect the
relative fault of the indemnifying party and the indemnified party, as well as any other relevant equitable considerations. The relative
fault of the indemnifying party and indemnified party shall be determined by reference to, among other things, whether any action in question,
including any untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact, was made
by, or relates to information supplied by, such indemnifying party or indemnified party, and the indemnifying party’s and indemnified
party’s relative intent, knowledge, access to information and opportunity to correct or prevent such action. The amount paid or
payable by a party as a result of the Losses or other liabilities referred to above shall be deemed to include, subject to the limitations
set forth above, any legal or other fees, charges or expenses reasonably incurred by such party in connection with any investigation or
proceeding. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall
be entitled to contribution pursuant to this Section 7(c) from any person who was not guilty of such fraudulent misrepresentation.

 

    10

     

    

 

d. For purposes of this Section 7,
“Shares” shall mean, as of any date of determination, the Shares acquired by the Investor pursuant to this Subscription Agreement
and any other equity security issued or issuable with respect to such Shares by way of share split, dividend, distribution, recapitalization,
merger, exchange, replacement or similar event, and “Investor” shall include any affiliate of the undersigned Investor to
which the rights under this Section 7 shall have been duly assigned.

 

e. FSII shall use its
commercially reasonable efforts to cause its transfer agent to remove the legend described in Section 6(b) and to issue a
certificate or a book entry record without such legend to the holder of the Shares upon which it is stamped or issue to such holder
by electronic delivery at the applicable balance account at The Depository Trust Company (“DTC”) within five (5)
business days of the Investor’s request to do so, if (i) such Shares are registered for resale under the Securities Act, upon
the sale thereof or (ii) the Shares can be sold, assigned or transferred without restriction or current public information
requirements pursuant to Rule 144, including without limitation, any volume and manner of sale restrictions which may be applicable
to affiliates under Rule 144 and any requirement for FSII to be in compliance with the current public information required under
Rule 144(c) or Rule 144(i), as applicable, and in each case, FSII shall provide its transfer agent such instructions and, if
required, shall request its legal counsel to deliver an opinion, with respect to such request, provided
that  the holder provides FSII, its transfer agent and its legal counsel, as applicable, with an undertaking to effect any
sales or other transfers in accordance with the Securities Act and other customary
representations and other documentation, if any, as reasonably requested by FSII, its transfer agent or its legal counsel,
establishing that restrictive legends are no longer required. FSII shall be responsible for the fees of the transfer agent
and all DTC fees associated with such issuance. The Investor shall be responsible for all other fees and expenses (including,
without limitation, any applicable broker fees, fees and disbursements of their legal counsel and any applicable transfer
taxes).

 

8. Termination.
This Subscription Agreement shall terminate and be void and of no further force and effect, and all rights and obligations of the
parties hereunder shall terminate without any further liability on the part of any party in respect thereof, upon the earlier to
occur of (a) such date and time as the Transaction Agreement is terminated in accordance with its terms, (b) upon the mutual written
agreement of each of the parties hereto to terminate this Subscription Agreement, (c) if any of the conditions to Closing set forth
in Section 3 of this Subscription Agreement are not satisfied or waived, or are not capable of being satisfied, on or prior
to the Closing and, as a result thereof, the transactions contemplated by this Subscription Agreement will not be and are not
consummated at the Closing or (d) if the Closing has not occurred by January 28, 2022 (the “Outside Date”)
(provided, that the right to terminate this Subscription Agreement pursuant to this clause (d) shall not be available to the
Investor if the Investor’s breach of any of its covenants or obligations under this Subscription Agreement (or if an affiliate
of the Investor is one of the Investors under an Other Subscription Agreement, and such other Investor’s breach of any of its
covenants or obligations under the Other Subscription Agreement), either individually or in the aggregate, shall have proximately
caused the failure of the consummation of the Transaction on or before the Outside Date) (the termination events described in
clauses (a) through (d) above, collectively, the “Termination Events”); provided that nothing herein will
relieve any party from liability for any willful breach hereof prior to the time of termination, and each party will be entitled to
any remedies at law or in equity to recover losses, liabilities or damages arising from any such breach. FSII shall notify the
Investor of the termination of the Transaction Agreement promptly after the termination of such agreement. Upon the occurrence of
any Termination Event, any monies paid by the Investor to FSII in connection herewith shall promptly (and in any event within one
business day) following the Termination Event be returned to the Investor.

 

    11

     

    

 

9. Trust Account Waiver.
The Investor hereby acknowledges that FSII has established a trust account (the “Trust Account”) containing the proceeds
of its initial public offering (the “IPO”) and from certain private placements occurring simultaneously with the IPO
(including interest accrued from time to time thereon) for the benefit of the Public Stockholders and certain other parties (including
the underwriters of the IPO). For and in consideration of FSII entering into this Subscription Agreement, and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the Investor hereby agrees that it does not now and shall
not at any time hereafter have any right, title, interest or claim of any kind in or to any assets held in the Trust Account, and shall
not make any claim against the Trust Account, regardless of whether such claim arises as a result of, in connection with or relating in
any way to this Subscription Agreement or any other matter, and regardless of whether such claim arises based on contract, tort, equity
or any other theory of legal liability (any and all such claims are collectively referred to hereafter as the “Released Claims”).
The Investor hereby irrevocably waives any Released Claims that it may have against the Trust Account now or in the future as a result
of, or arising out of, any discussions, contracts or agreements with FSII and will not seek recourse against the Trust Account for any
reason whatsoever; provided, however, that nothing in this Section 9 shall be deemed to limit the Investor’s right to distributions
from the Trust Account in accordance with FSII’s certificate of incorporation in respect of any redemptions by the Investor in respect
of Shares acquired by means other than pursuant to this Subscription Agreement. Nothing in this Section 9 shall be deemed to limit the
Investor’s right, title, interest or claim to any monies held in the Trust Account by virtue of its record or beneficial ownership
of Shares currently outstanding on the date hereof, pursuant to a validly exercised redemption right with respect to any such Shares,
except to the extent that the Investor has otherwise agreed with FSII to not exercise such redemption right.

 

10. Miscellaneous.

 

a. Neither this Subscription
Agreement nor any rights that may accrue to the Investor hereunder (other than the Shares acquired hereunder, if any) may be transferred
or assigned other than an assignment to any fund or account managed by the same investment manager as the Investor or an affiliate thereof.

 

b. FSII may request from the
Investor such additional information as FSII may deem necessary to evaluate the eligibility of the Investor to acquire the Shares, and
the Investor shall promptly provide such information as may reasonably be requested to the extent readily available and to the extent
consistent with its internal policies and procedures; provided, that, FSII agrees to keep any such information provided by the Investor
confidential. The Investor acknowledges that FSII may file a copy of this Subscription Agreement with the SEC as an exhibit to a periodic
report of FSII or a registration statement of FSII.

 

c. The Investor acknowledges
that FSII, the Placement Agents (as third party beneficiaries with the right to enforce Section 5, Section 6, Section
10 and Section 11 hereof on their own behalf and not, for the avoidance of doubt, on behalf of FSII or Target) will rely on
the acknowledgments, understandings, agreements, representations and warranties contained in this Subscription Agreement. Prior to the
Closing, the Investor agrees to promptly notify FSII and the Placement Agents if any of the acknowledgments, understandings, agreements,
representations and warranties set forth herein are no longer accurate in any material respect (other than those acknowledgements, understandings,
agreements, representations and warranties qualified by materiality, in which case the Investor shall notify FSII and the Placement Agents
if they are no longer accurate in any respect).

 

d. FSII acknowledges that the
Investor and the Placement Agents (as third-party beneficiaries with the right to enforce Sections 5, Section 6, Section
10 and Section 11 hereof on their own behalf and not, for the avoidance of doubt, on behalf of the Investor or FSII) will
rely on the acknowledgments, understandings, agreements, representations and warranties of FSII contained in this Subscription Agreement.
Prior to the Closing, FSII agrees to promptly notify the Investor and the Placement Agents if any of the acknowledgments, understandings,
agreements, representations and warranties set forth herein are no longer accurate in any material respect (other than those acknowledgements,
understandings, agreements, representations and warranties qualified by materiality, in which case FSII shall notify the Investor and
the Placement Agents if they are no longer accurate in any respect).

 

e. FSII and the Placement Agents
are each entitled to rely upon this Subscription Agreement and each is irrevocably authorized to produce this Subscription Agreement or
a copy hereof to any interested party in any administrative or legal proceeding or official inquiry with respect to the matters covered
hereby, provided, however, that the foregoing shall not give the Placement Agents any rights other than
those expressly set forth herein.

 

f. All of the agreements, representations
and warranties made by each party hereto in this Subscription Agreement shall survive the Closing.

 

g. This Subscription Agreement
may not be modified, waived or terminated except by an instrument in writing, signed by each of the parties hereto. No failure or delay
of either party in exercising any right or remedy hereunder shall operate as a waiver thereof, nor shall any single or partial exercise
of any such right or power, or any abandonment or discontinuance of steps to enforce such right or power, or any course of conduct, preclude
any other or further exercise thereof or the exercise of any other right or power. The rights and remedies of the parties hereunder are
cumulative and are not exclusive of any rights or remedies that they would otherwise have hereunder.

 

    12

     

    

 

h. This Subscription Agreement
(including the schedule hereto) constitutes the entire agreement, and supersedes all other prior agreements, understandings, representations
and warranties, both written and oral, among the parties, with respect to the subject matter hereof. Except as set forth in Section
7(c), Section 10(c), Section 10(d), Section 10(e) and Section 11, this Subscription Agreement shall not
confer any rights or remedies upon any person other than the parties hereto, and their respective successor and assigns.

 

i. Except as otherwise provided
herein, this Subscription Agreement shall be binding upon, and inure to the benefit of the parties hereto and their heirs, executors,
administrators, successors, legal representatives, and permitted assigns, and the agreements, representations, warranties, covenants and
acknowledgments contained herein shall be deemed to be made by, and be binding upon, such heirs, executors, administrators, successors,
legal representatives and permitted assigns.

 

j. If any provision of this
Subscription Agreement shall be adjudicated by a court of competent jurisdiction to be invalid, illegal or unenforceable, the validity,
legality or enforceability of the remaining provisions of this Subscription Agreement shall not in any way be affected or impaired thereby
and shall continue in full force and effect.

 

k. This Subscription Agreement
may be executed in one or more counterparts (including by facsimile or electronic transmission or in .pdf) and by different parties in
separate counterparts, with the same effect as if all parties hereto had signed the same document. All counterparts so executed and delivered
shall be construed together and shall constitute one and the same agreement.

 

l. The parties hereto agree
that irreparable damage would occur in the event that any of the provisions of this Subscription Agreement were not performed in accordance
with their specific terms or were otherwise breached. It is accordingly agreed that the parties shall be entitled to an injunction or
injunctions to prevent breaches of this Subscription Agreement, without posting a bond or undertaking and without proof of damages, to
enforce specifically the terms and provisions of this Subscription Agreement, this being in addition to any other remedy to which such
party is entitled at law, in equity, in contract, in tort or otherwise.

 

m. THE PARTIES HERETO IRREVOCABLY
SUBMIT TO THE EXCLUSIVE JURISDICTION OF THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK AND THE SUPREME COURT OF
THE STATE OF NEW YORK SOLELY IN RESPECT OF THE INTERPRETATION AND ENFORCEMENT OF THE PROVISIONS OF THIS SUBSCRIPTION AGREEMENT AND THE
DOCUMENTS REFERRED TO IN THIS SUBSCRIPTION AGREEMENT AND IN RESPECT OF THE TRANSACTIONS CONTEMPLATED HEREBY, AND HEREBY WAIVE, AND AGREE
NOT TO ASSERT, AS A DEFENSE IN ANY ACTION, SUIT OR PROCEEDING FOR INTERPRETATION OR ENFORCEMENT HEREOF OR ANY SUCH DOCUMENT THAT IS NOT
SUBJECT THERETO OR THAT SUCH ACTION, SUIT OR PROCEEDING MAY NOT BE BROUGHT OR IS NOT MAINTAINABLE IN SAID COURTS OR THAT VENUE THEREOF
MAY NOT BE APPROPRIATE OR THAT THIS SUBSCRIPTION AGREEMENT OR ANY SUCH DOCUMENT MAY NOT BE ENFORCED IN OR BY SUCH COURTS, AND THE PARTIES
HERETO IRREVOCABLY AGREE THAT ALL CLAIMS WITH RESPECT TO SUCH ACTION, SUIT OR PROCEEDING SHALL BE HEARD AND DETERMINED BY SUCH A NEW YORK
STATE OR FEDERAL COURT. THE PARTIES HEREBY CONSENT TO AND GRANT ANY SUCH COURT JURISDICTION OVER THE PERSON OF SUCH PARTIES AND OVER THE
SUBJECT MATTER OF SUCH DISPUTE AND AGREE THAT MAILING OF PROCESS OR OTHER PAPERS IN CONNECTION WITH SUCH ACTION, SUIT OR PROCEEDING IN
THE MANNER PROVIDED IN SECTION 10(m) OF THIS SUBSCRIPTION AGREEMENT OR IN SUCH OTHER MANNER AS MAY BE PERMITTED BY LAW SHALL BE
VALID AND SUFFICIENT SERVICE THEREOF.

 

    13

     

    

 

EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY
WHICH MAY ARISE UNDER THIS SUBSCRIPTION AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT
ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN
RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS SUBSCRIPTION AGREEMENT OR THE TRANSACTIONS CONTEMPLATED
BY THIS SUBSCRIPTION AGREEMENT. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (I) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY
HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER;
(II) SUCH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THE FOREGOING WAIVER; (III) SUCH PARTY MAKES THE FOREGOING WAIVER VOLUNTARILY
AND (IV) SUCH PARTY HAS BEEN INDUCED TO ENTER INTO THIS SUBSCRIPTION AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVER AND CERTIFICATIONS
IN THIS SECTION 10(l).

 

n. All notices, requests, demands,
claims, and other communications hereunder shall be in writing. Any notice, request, demand, claim, or other communication hereunder shall
be deemed duly given (i) when delivered personally to the recipient, (ii) when sent by electronic mail, on the date of transmission to
such recipient; provided, that such notice, request, demand, claim or other communication is also sent to the recipient pursuant
to clauses (i), (iii) or (iv) of this Section 10(m), (iii) one business day after being sent to the recipient by reputable overnight
courier service (charges prepaid) or (iv) five (5) business days after being mailed to the recipient by certified or registered mail,
return receipt requested and postage prepaid, and, in each case, addressed to the intended recipient at its address specified on the signature
page hereof or to such electronic mail address or address as subsequently modified by written notice given in accordance with this Section
10(m). All communications sent to FSII shall be sent to: FS Development Corp. II, 900 Larkspur Landing Circle, Suite 150, Larkspur, CA 94939, Attn: Jim Tananbaum, email: jim@foresitecapital.com, with a copy to: White & Case LLP, 1221 Avenue of the Americas,
New York, New York 10020, Attn: Joel L. Rubinstein, Esq., email: joel.rubinstein@whitecase.com.

 

11. Non-Reliance and Exculpation.

 

a. The Investor acknowledges
that it is not relying upon, and has not relied upon, any statement, representation or warranty made by any person, firm or corporation
(including, without limitation, the Placement Agents, any of their respective affiliates
or any of their or their respective affiliates’ control persons, officers, directors and employees), other than the statements,
representations and warranties of FSII expressly contained in Section 5 of this Subscription Agreement, in making its investment
or decision to invest in FSII. The Investor agrees that none of (i) any of the Other Investors pursuant to this Subscription Agreement
or any Other Subscription Agreement related to the private placement of the Shares (including the respective controlling persons, officers,
directors, partners, agents, or employees of any Other Investor), (ii) the Placement Agents, their
respective affiliates or any of their or their respective affiliates’ control persons, officers, directors or employees
or (iii) any other party to the Transaction Agreement, including any such party’s representatives, affiliates
or any of its or their control persons, officers, directors or employees, that is not a party hereto shall be liable to the Investor
or any other investor pursuant to this Subscription Agreement or any Other Subscription Agreement related to the private placement of
the Shares for any action heretofore or hereafter taken or omitted to be taken by any of them in connection with the purchase of the
Shares.

 

b. Without limiting the generality
of Section 11(a) or any other provision in this Subscription Agreement, each party hereto agrees for the express benefit of the
Placement Agents, their respective affiliates and their respective representatives that: (i) neither the Placement Agents nor any of their
affiliates or any of their representatives (1) shall be liable for any improper payment made in accordance with the information provided
by FSII; (2) make any representation or warranty, or have any responsibilities as to the validity, accuracy, value or genuineness of any
information, certificates or documentation delivered by or on behalf of FSII pursuant to this Subscription Agreement or any agreement
contemplated therein, or in connection with the Transaction; or (3) shall be liable (x) for any action taken, suffered or omitted by any
of them in good faith and reasonably believed to be authorized or within the discretion or rights or powers conferred upon them by this
Subscription Agreement or any agreement contemplated therein or (y) for anything which any of them may do or refrain from doing in connection
with this Subscription Agreement, except, with respect to clause (3) only, for such party’s own gross negligence, willful misconduct
or bad faith; and (ii) the Placement Agents, their affiliates and their representatives shall be entitled to rely on, and shall be protected
in acting upon, any certificate, instrument, opinion, notice, letter or any other document or security delivered to any of them by or
on behalf of FSII.

 

    14

     

    

 

12. Disclosure. FSII
shall, by 9:00 a.m., New York City time, on the first business day immediately following the date of this Subscription Agreement, issue
one or more press releases to furnish or file with the SEC a Current Report on Form 8-K (collectively, the “Disclosure Document”)
disclosing, to the extent not previously publicly disclosed, the transactions contemplated hereby, all material terms of the Transaction
and any other material, non-public information that FSII has provided to the Investor at any time prior to the filing of the Disclosure
Document. From and after the disclosure of the Disclosure Document, to the knowledge of FSII, the Investor shall not be in possession
of any material, non-public information received from FSII or any of its officers, directors or employees. Notwithstanding the foregoing,
FSII shall not publicly disclose the name of the Investor or any affiliate or investment adviser of the Investor, or include the name
of the Investor or any affiliate or investment adviser of the Investor in any press release or in any filing with the SEC or any regulatory
agency or trading market, without the prior written consent (including by e-mail) of the Investor, except as required by the federal
securities laws, rules or regulations, and to the extent such disclosure is required by other laws, rules or regulations, at the request
of the staff of the SEC or regulatory agency or under the Nasdaq regulations, in which case FSII shall provide the Investor with prior
written notice (including by e-mail) of such permitted disclosure, and shall reasonably consult with the Investor regarding such disclosure.

 

[SIGNATURE PAGES FOLLOW]

 

    15

     

    

 

IN WITNESS WHEREOF, the Investor has executed
or caused this Subscription Agreement to be executed by its duly authorized representative as of the date set forth below.

 

	Name of Investor:	 	State/Country of Formation or Domicile:
	 	                 	 	 
	By:	 	 	 
	 	 	 	 
	Name: 	 	 	 
	 	 	 	 
	Title:	 	 	 
	 	 	 
	Name in which Shares are to be registered (if different):	 	Date: ________, 2021
	 	 	 
	Investor’s EIN:	 	 
	 	 	 
	Business Address-Street:	 	Mailing Address-Street (if different):
	 	 	 
	City, State, Zip:	 	City, State, Zip:
	 	 	 	 	                 
	Attn:	 	 	Attn:   	 
	 	 	 
	Email:	 	Email:
	 	 	 
	Telephone No.:	 	Telephone No.:
	 	 	 
	Facsimile No.:	 	Facsimile No.:
	 	 	 
	Number of Shares subscribed for:	 	 
	 	 	 
	Aggregate Subscription Amount: $	 	Price Per Share: $10

 

You must pay the Subscription
Amount by wire transfer of United States dollars in immediately available funds to the account specified by FSII in the Closing Notice.

 

    16

     

    

 

IN WITNESS WHEREOF, FSII has accepted this Subscription
Agreement as of the date set forth below.

 

	 	By:	 
	 	Name:	 
	 	Title:	 

 

Date:                        , 2021

 

    17

     

    

 

SCHEDULE A

 

ELIGIBILITY REPRESENTATIONS
OF THE INVESTOR

 

	A.	QUALIFIED INSTITUTIONAL BUYER STATUS

	 	(Please check the applicable subparagraphs):

 

☐  We
are a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act (a “QIB”)).

 

	B.	INSTITUTIONAL ACCREDITED INVESTOR STATUS

 

	 	(Please check the applicable subparagraphs):

 

	 	1.	☐  We are an “accredited investor” within the meaning of Rule 501(a) under the Securities Act or an entity in which all of the equity holders are accredited investors within the meaning of Rule 501(a) under the Securities Act, and have marked and initialed the appropriate box below indicating the provision under which we qualify as an “accredited investor.”

 

	 	2.	☐  We are not a natural person.

 

Rule 501(a), in relevant part, states that
an “accredited investor” shall mean any person who comes within any of the below listed categories, or who the issuer reasonably
believes comes within any of the below listed categories, at the time of the sale of the securities to that person. The Investor has indicated,
by marking and initialing the appropriate box below, the provision(s) below which apply to the Investor and under which the Investor accordingly
qualifies as an “accredited investor.”

 

☐  Any
bank, registered broker or dealer, insurance company, registered investment company, business development company, or small business investment
company;

 

☐  Any
plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political subdivisions
for the benefit of its employees, if such plan has total assets in excess of $5,000,000;

 

☐  Any
employee benefit plan, within the meaning of the Employee Retirement Income Security Act of 1974, if a bank, insurance company, or registered
investment adviser makes the investment decisions, or if the plan has total assets in excess of $5,000,000;

 

☐  Any
organization described in Section 501(c)(3) of the Internal Revenue Code, corporation, similar business trust, or partnership, not
formed for the specific purpose of acquiring the securities offered, with total assets in excess of $5,000,000;

 

☐
Any trust with assets in excess of $5,000,000, not formed to acquire the securities offered, whose purchase is directed by a sophisticated
person; or

 

☐ Any
entity in which all of the equity owners are accredited investors meeting one or more of the above tests.

 

C. INSTITUTIONAL ACCOUNTS STATUS

 

☐  We
are an “institutional account” (as defined in FINRA RULE 4512(c)).

 

    18

     

    

 

D. ACCREDITED INVESTOR STATUS

 

	 	(Please check the applicable subparagraphs):

 

	 	1.	☐  I am an “accredited investor” within the meaning of Rule 501(a) under the Securities Act or an entity in which all of the equity holders are accredited investors within the meaning of Rule 501(a) under the Securities Act, and have marked and initialed the appropriate box below indicating the provision under which we qualify as an “accredited investor.”

 

	 	2.	☐  I am a natural person.

 

Rule 501(a), in relevant part, states that
an “accredited investor” shall mean any person who comes within any of the below listed categories, or who the issuer reasonably
believes comes within any of the below listed categories, at the time of the sale of the securities to that person. The Investor has indicated,
by marking and initialing the appropriate box below, the provision(s) below which apply to the Investor and under which the Investor accordingly
qualifies as an “accredited investor.”

 

☐  Any
director, executive officer, or general partner of the issuer of the securities being offered or sold, or any director, executive officer,
or general partner of a general partner of that issuer;

 

☐
Any natural person whose individual net worth, or joint net worth with that person’s spouse, at the time of his purchase
exceeds $1,000,000. For purposes of calculating a natural person’s net worth: (a) the person’s primary residence must not
be included as an asset; (b) indebtedness secured by the person’s primary residence up to the estimated fair market value of the
primary residence must not be included as a liability (except that if the amount of such indebtedness outstanding at the time of calculation
exceeds the amount outstanding 60 days before such time, other than as a result of the acquisition of the primary residence, the amount
of such excess must be included as a liability); and (c) indebtedness that is secured by the person’s primary residence in excess
of the estimated fair market value of the residence must be included as a liability; or

 

☐ Any
natural person who had an individual income in excess of $200,000 in each of the two most recent years or joint income with that person’s
spouse in excess of $300,000 in each of those years and has a reasonable expectation of reaching the same income level in the current
year. 

 

This page should
be completed by the Investor

 

and constitutes
a part of the Subscription Agreement.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}]]